MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31.

Income Overview

Net Income
-$39,869K
EPS
-$17.98
Unit: Thousand (K) dollars

Income Statement
2025-12-31
Research and development
29,183
General and administrative
12,266
Total operating expenses
41,449
Loss from operations
-41,449
Interest income
3,106
Change in fair value of redeemable convertible preferred stock tranche liability
1,526
Total other income (expense)
1,580
Loss before income tax
-39,869
Federal
0
State
0
Foreign
0
Total current taxes
0
Federal
8,704
State
1,206
Foreign
0
Total deferred taxes
9,910
Valuation allowance
-9,910
Income tax provision
0
Net loss
-39,869
Basic EPS
-17.98
Diluted EPS
-17.98
Basic Average Shares
2,217,104
Diluted Average Shares
2,217,104
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss-$39,869K Interest income$3,106K Loss before incometax-$39,869K Total other income(expense)$1,580K Change in fair value ofredeemable convertible...$1,526K Loss from operations-$41,449K Total operatingexpenses$41,449K Research and development$29,183K General andadministrative$12,266K

SpyGlass Pharma, Inc. (SGP)

SpyGlass Pharma, Inc. (SGP)